Trogarzo 62064-0122

Generic: Ibalizumab

Product NDC

62064-0122

Manufacturer: Theratechnologies Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 20, 2018
Listing Expires: December 31, 2027
Application: BLA761065

Need to source Trogarzo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ibalizumab	150 mg/mL

Drug Class

CD4-directed Blocking Antibody [EPC]Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]Antibodies

Packaging Options(1)

62064-0122-02

2 VIAL, SINGLE-USE in 1 CARTON (62064-122-02) / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01)

View →